Skip to main content
. Author manuscript; available in PMC: 2025 Sep 27.
Published in final edited form as: Quintessence Int. 2024 Sep 27;55(8):652–659. doi: 10.3290/j.qi.b5733611

Table 3.

Practitioners to whom patients with oral lesions suspicious for premalignancy or malignancy were generally referred (n=1069).

n (%)
 Oral / Maxillofacial Surgeon 932 (87.2)
 Oral Pathologist 58 (5.4)
 Ear Nose Throat Specialist 27 (2.5)
 Oral Medicine Specialist 26 (2.4)
 Periodontist (Other) 9 (0.8)
 Head & Neck Surgeon 3 (0.3)
 Depends on lesion (OMF, ENT or Oral Pathologist) 3 (0.3)
 Dermatologist 2 (0.2)
 Primary Care Physician 2 (0.2)
 Cancer hospital, Oral Oncologist 2 (0.2)
Five GDs reported that they did not refer patients with oral lesions:
 Do not refer patients with oral lesions 2 (0.2)
 Suspicious for Malignancy / Premalignancy
 Do not refer patients with oral lesions; 3 (0.3)
  patients are referred to me
 Total 1,069 (100)

Note: Two GDs who responded to the type of practitioner question did not respond to questions regarding personally performing biopsies and referrals.